The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1,3-Bis(4-((6-methoxyquinolin-8-yl)amino)pentyl)urea ID: ALA1739045
PubChem CID: 53326072
Max Phase: Preclinical
Molecular Formula: C31H40N6O3
Molecular Weight: 544.70
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(NC(C)CCCNC(=O)NCCCC(C)Nc2cc(OC)cc3cccnc23)c2ncccc2c1
Standard InChI: InChI=1S/C31H40N6O3/c1-21(36-27-19-25(39-3)17-23-11-7-13-32-29(23)27)9-5-15-34-31(38)35-16-6-10-22(2)37-28-20-26(40-4)18-24-12-8-14-33-30(24)28/h7-8,11-14,17-22,36-37H,5-6,9-10,15-16H2,1-4H3,(H2,34,35,38)
Standard InChI Key: VBDUDTPBEHEYTA-UHFFFAOYSA-N
Molfile:
RDKit 2D
40 43 0 0 0 0 0 0 0 0999 V2000
-6.4586 -10.5257 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4527 -12.0265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7491 -12.7828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7433 -14.2836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0396 -15.0399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0338 -16.5407 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-10.0813 -14.4443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3301 -17.2970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9121 -18.8145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9324 -17.3017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.6413 -16.5434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.6100 -19.5532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3189 -18.7949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0168 -19.5336 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-9.0058 -21.0307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.2968 -21.7889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.5989 -21.0502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.2362 -16.5586 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-14.2436 -15.3586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9091 1.5019 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9072 2.7019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2907 -2.9981 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5870 -3.7544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6288 -3.1588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5812 -5.2552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8775 -6.0115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8717 -7.5123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1681 -8.2686 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1622 -9.7694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1205 -10.3650 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20 21 1 0
2 3 1 0
8 11 2 0
12 9 1 0
9 10 2 0
20 23 2 0
21 22 2 0
22 25 1 0
24 23 1 0
24 25 2 0
10 11 1 0
12 13 2 0
5 6 1 0
1 2 1 0
5 7 1 0
3 4 1 0
24 29 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
6 8 1 0
20 30 1 0
8 13 1 0
30 31 1 0
12 17 1 0
22 32 1 0
13 14 1 0
32 33 1 0
14 15 2 0
33 34 1 0
15 16 1 0
33 35 1 0
16 17 2 0
35 36 1 0
36 37 1 0
10 18 1 0
37 38 1 0
4 5 1 0
38 39 1 0
18 19 1 0
39 40 2 0
39 1 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 544.70Molecular Weight (Monoisotopic): 544.3162AlogP: 5.96#Rotatable Bonds: 14Polar Surface Area: 109.43Molecular Species: NEUTRALHBA: 7HBD: 4#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 4.36CX LogP: 3.62CX LogD: 3.62Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.15Np Likeness Score: -0.54
References 1. Pavić K, Perković I, Cindrić M, Pranjić M, Martin-Kleiner I, Kralj M, Schols D, Hadjipavlou-Litina D, Katsori AM, Zorc B.. (2014) Novel semicarbazides and ureas of primaquine with bulky aryl or hydroxyalkyl substituents: synthesis, cytostatic and antioxidative activity., 86 [PMID:25203780 ] [10.1016/j.ejmech.2014.09.013 ] 2. Levatić J, Pavić K, Perković I, Uzelac L, Ester K, Kralj M, Kaiser M, Rottmann M, Supek F, Zorc B.. (2018) Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity., 146 [PMID:29407988 ] [10.1016/j.ejmech.2018.01.062 ] 3. Pavić K, Perković I, Pospíšilová Š, Machado M, Fontinha D, Prudêncio M, Jampilek J, Coffey A, Endersen L, Rimac H, Zorc B.. (2018) Primaquine hybrids as promising antimycobacterial and antimalarial agents., 143 [PMID:29220797 ] [10.1016/j.ejmech.2017.11.083 ]